AdvaMed Pleads Its Case on Medical Device Tariffs
AdvaMed wants to work with the Trump administration to recognize and reward the unique strength of the U.S. medtech industry.
AdvaMed CEO and President Scott Whitaker stated:
to recognize and to reward the unique strength of the U.S. medtech industrywith supportive policies.
In comments submitted to Commerce Secretary, AdvaMed offered an overview of the domestic medtech industry, including recent investments in the U.S., employment growth, and R&D spending driving medical innovation.
- Seeking fair and reciprocal tariff-free trade with important allies
- Addressing unfair market access barriers in specific countries
- Advancing domestic regulatory reforms and procurement incentives to enhance U.S.
Author's summary: AdvaMed seeks Trump administration support.
More News
- Illinois PIRG: State Farm's influence blocks regulators' probe
- Using ‘integration’ to silence culturally specific care - Healthy Debate
- Scotland’s New Rent Controls Put Starmer’s Measly Reforms to Shame | Novara Media
- Donald Trump "No Kings" AI Poop Jet Video | Know Your Meme
- High winds across parts of Colorado create fire danger Monday
- Illinois SNAP errors could cost taxpayers up to $700 million in penalties
- Veteran actor Asrani passes away aged 84
- Rodrigo Paz Wins: Bolivia's Electoral Context in Five Charts
- The Internet Never Forgets: Tyler, The Creator In Hot Water After Old Tweets Resurface
- Apple Stock Powers the Dow After iPhone Sales, Bull Notes - Schaeffer's Investment Research